Bonus & Incentive Agreements in the Health Care Equipment & Supplies Industry

2,898 Contracts & Agreements

Browse by Company

Abbott Laboratories (56 contracts)
ABIOMED Inc (31)
Accelerate Diagnostics, Inc (7)
ACCURAY INC (12)
Acrivon Therapeutics, Inc. (2)
ACTUATE THERAPEUTICS, INC. (4)
Acutus Medical, Inc. (5)
Adams Respiratory Therapeutics, Inc. (3)
ADC Therapeutics SA (2)
ADNEXUS THERAPEUTICS, INC. (4)
AdvanSource Biomaterials Corp (2)
AETHLON MEDICAL INC (4)
Affinia Therapeutics Inc. (1)
AIT Therapeutics, Inc. (1)
Align Technology (33)
ALLIED HEALTHCARE PRODUCTS INC (1)
ALLOS THERAPEUTICS INC (15)
Alphatec Holdings, Inc. (15)
Angiodynamics Inc (25)
ANTARES PHARMA, INC. (6)
Apogee Therapeutics, Inc. (4)
Apollo Endosurgery, Inc. (12)
AquaMed Technologies, Inc. (7)
ARATANA THERAPEUTICS, INC. (7)
Arch Therapeutics, Inc. (6)
ARGOS THERAPEUTICS INC (17)
Arno Therapeutics, Inc (7)
AtriCure, Inc. (30)
ATRION CORP (18)
Audentes Therapeutics, Inc. (4)
Avanos Medical Inc (1)
Avinger Inc (9)
AxoGen, Inc. (14)
Axonics Modulation Technologies, Inc. (11)
Bausch & Lomb Corp (25)
Baxter International Inc. (4)
Becton Dickinson (8)
Bellerophon Therapeutics, Inc. (7)
Bicara Therapeutics Inc. (1)
BIOCANCELL THERAPEUTICS INC. (3)
BIOLASE, INC (7)
BIOLIFE SOLUTIONS INC (2)
BIOMERICA INC (1)
BIOMIMETIC THERAPEUTICS, INC. (2)
BioSig Technologies, Inc. (11)
Bioventus Inc. (7)
Boston Scientific (124)
BRAIN SCIENTIFIC INC. (2)
Cadrenal Therapeutics, Inc. (7)
Cantel Medical Corporation (23)
Cardiovascular Systems Inc (54)
CARGO Therapeutics, Inc. (4)
Carmot Therapeutics Inc. (2)
Cascadian Therapeutics, Inc. (4)
CERUS CORP (23)
CESCA THERAPEUTICS INC. (12)
CHEMBIO DIAGNOSTICS, INC. (11)
CHF Solutions, Inc. (21)
Chromocell Therapeutics Corp (3)
Cirius Therapeutics, Inc. (2)
Civitas Therapeutics, Inc. (13)
CLARUS THERAPEUTICS INC (1)
Co-Diagnostics, Inc. (1)
Colfax CORP (27)
Conformis Inc (17)
CONMED Corporation (1)
Contineum Therapeutics, Inc. (2)
CORNERSTONE THERAPEUTICS INC (19)
Coronado Topco, Inc. (1)
Coya Therapeutics, Inc. (2)
CryoLife, Inc. (42)
Cryoport, Inc. (11)
Cue Health Inc. (10)
Cutera, Inc. (11)
CV THERAPEUTICS INC (3)
CVRx, Inc. (2)
Cytosorbents Corp (2)
D8 Holdings Corp. (5)
Danaher Corp. (79)
Dare Bioscience, Inc. (16)
DarioHealth Corp. (6)
DELCATH SYSTEMS, INC. (15)
Dentsply Sirona (13)
DEXCOM INC (7)
Dimension Therapeutics, Inc. (1)
Durata Therapeutics, Inc. (9)
DYNATRONICS CORP (4)
Eargo, Inc. (6)
Echo Therapeutics, Inc. (1)
Edwards Lifesciences (18)
EKSO BIONICS HOLDINGS, INC. (2)
electroCore, Inc. (17)
Electromed, Inc. (18)
Elicio Therapeutics, Inc. (2)
EMULATE THERAPEUTICS, INC. (2)
ENDOLOGIX INC (9)
ENDRA Life Sciences Inc. (5)
Envista Holdings Corp (8)
ERBA Diagnostics, Inc. (1)
ESTABLISHMENT LABS HOLDINGS INC. (8)
Felicitex Therapeutics Inc. (3)
FEMASYS INC (3)
FIGS, Inc. (8)
GenMark Diagnostics, Inc. (2)
GI DYNAMICS, INC. (5)
GLAUKOS Corp (8)
Globus Medical Inc. (7)
Glolex, Inc. (2)
Glucose Biosensor Systems (Greater China) Holdings, Inc. (4)
Haemonetics (34)
Hancock Jaffe Laboratories, Inc. (7)
HealthCor Catalio Acquisition Corp. (7)
Heart Test Laboratories, Inc. (2)
HELIUS MEDICAL TECHNOLOGIES, INC. (14)
Heska Corporation (47)
Hill-Rom Holdings Inc. (17)
Holly Brothers Pictures, Inc. (2)
Hologic (64)
HYPERION THERAPEUTICS INC (8)
ICU Medical (8)
IDEXX Laboratories (19)
Inari Medical, Inc. (9)
Innovative Eyewear Inc (1)
Inogen, Inc. (24)
InspireMD, Inc. (19)
INSULET CORP (66)
Insys Therapeutics, Inc. (9)
INTARCIA THERAPEUTICS, INC (3)
Integer Holdings Corporation (24)
Integra Lifesciences Holdings (34)
Integrity Applications, Inc. (3)
INTENSITY THERAPEUTICS, INC. (2)
INTRICON CORP (5)
Intuitive Surgical Inc. (28)
Invacare Corporation (9)
Invea Therapeutics, Inc (3)
INVIVO THERAPEUTICS HOLDINGS CORP. (10)
IRADIMED CORP (8)
iRhythm Technologies, Inc. (3)
IRIDEX CORP (6)
Juno Therapeutics, Inc. (14)
KEWAUNEE SCIENTIFIC CORP (17)
Kyverna Therapeutics, Inc. (5)
Lantheus Holdings, Inc. (22)
LeMaitre Vascular, Inc. (12)
LENSAR, Inc. (8)
Lexeo Therapeutics, Inc. (3)
Lirum Therapeutics, Inc. (1)
LivaNova (31)
Longview Acquisition Corp. (8)
Lucid Diagnostics Inc. (1)
Lucira Health, Inc. (7)
MABVAX THERAPEUTICS HOLDINGS, INC. (6)
Masimo (9)
Medtronic plc (39)
MELINTA THERAPEUTICS, INC. (5)
Meridian Bioscience, Inc. (28)
Merit Medical Systems, Inc. (22)
MESA LABORATORIES INC (5)
METABASIS THERAPEUTICS INC (4)
MICRO THERAPEUTICS INC (1)
Microbot Medical Inc. (1)
MICRON SOLUTIONS INC (1)
Mineralys Therapeutics, Inc. (4)
MINERVA SURGICAL INC (2)
MISONIX INC (2)
Modular Medical, Inc. (8)
Motus GI Holdings, Inc. (3)
MRI INTERVENTIONS, INC. (9)
MYOMO INC (2)
NanoVibronix, Inc. (7)
Natus Medical Incorporated (4)
Neumora Therapeutics, Inc. (6)
NeuroMetrix, Inc. (8)
Neuronetics, Inc. (10)
NEUROONE MEDICAL TECHNOLOGIES Corp (4)
NeuroPace Inc (2)
NEVRO CORP (7)
NEXEON MEDSYSTEMS INC (1)
Nightstar Therapeutics plc (1)
NON INVASIVE MONITORING SYSTEMS INC (1)
NOVELION THERAPEUTICS INC. (15)
NovoCure Ltd (18)
NuVasive Inc (22)
OBALON THERAPEUTICS INC (12)
Ocata Therapeutics, Inc. (2)
Ocera Therapeutics, Inc. (5)
OraSure Technologies, Inc. (4)
Orexigen Therapeutics, Inc. (5)
Orthofix Medical Inc. (45)
ORTHOPEDIATRICS CORP (3)
Outset Medical, Inc. (8)
Oxford Immunotec Global PLC (13)
OxySure Therapeutics, Inc. (3)
Pandion Therapeutics Holdco LLC (3)
Paragon 28, Inc. (3)
PAVmed Inc. (3)
Peloton Therapeutics, Inc. (3)
Penumbra Inc (9)
PERNIX THERAPEUTICS HOLDINGS, INC. (13)
PetVivo Holdings, Inc. (3)
Precision Therapeutics Inc. (9)
Presbia PLC (1)
Primus Therapeutics Inc. (1)
PRO DEX INC (4)
PROCEPT BioRobotics Corp (3)
Pulmonx Corp (2)
Pulse Biosciences, Inc. (4)
QUIDEL CORP (53)
Quotient Ltd (4)
Ra Medical Systems, Inc. (6)
REPROS THERAPEUTICS INC. (1)
ReShape Lifesciences Inc. (18)
ResMed (5)
Restoration Robotics, Inc. (14)
RetinalGenix Technologies Inc. (1)
ReWalk Robotics Ltd. (9)
ROCKWELL MEDICAL, INC. (9)
RTI Surgical Holdings, Inc. (2)
RTI SURGICAL, INC. (6)
RxSight, Inc. (3)
Sandbridge Acquisition Corp (6)
SANUWAVE Health, Inc. (3)
SeaSpine Holdings Corp (11)
SECOND SIGHT MEDICAL PRODUCTS INC (1)
Semler Scientific, Inc. (9)
Senseonics Holdings, Inc. (7)
Sensus Healthcare, Inc. (1)
Sharps Technology Inc. (3)
ShockWave Medical, Inc. (4)
SI-BONE, Inc. (5)
Sientra, Inc. (2)
Sight Sciences, Inc. (3)
Silk Road Medical Inc (9)
Sintx Technologies, Inc. (11)
SmileDirectClub, Inc. (6)
Sonendo, Inc. (4)
Spark Therapeutics, Inc. (6)
STAAR SURGICAL CO (10)
STEMLINE THERAPEUTICS INC (7)
Stereotaxis, Inc. (39)
STERIS Ltd (5)
STERIS plc (2)
STRATA Skin Sciences, Inc. (4)
Structure Therapeutics Inc. (8)
Stryker Corp. (34)
Surmodics, Inc. (17)
TACTILE SYSTEMS TECHNOLOGY INC (10)
Talis Biomedical Corp (4)
Talon Therapeutics, Inc. (3)
TANDEM DIABETES CARE INC (16)
Targanta Therapeutics Corp. (5)
TearLab Corp (3)
TechCare Corp. (3)
TELA Bio, Inc. (16)
Teleflex Inc (7)
Tenon Medical, Inc. (3)
The Cooper Companies (42)
Tivic Health Systems, Inc. (5)
Tobira Therapeutics, Inc. (5)
TRANSENTERIX INC. (19)
TransMedics Group, Inc. (11)
TREACE MEDICAL CONCEPTS, INC. (2)
Trius Therapeutics Inc (4)
Valeritas Holdings Inc. (5)
VAPOTHERM INC (21)
Varian Medical Systems (11)
Vector Therapeutics, Inc. (1)
VERMILLION, INC. (5)
ViewRay, Inc. (5)
VIVEVE MEDICAL, INC. (5)
Vividion Therapeutics, Inc. (2)
VIVOS INC (1)
VOLITIONRX LTD (10)
West Pharmaceutical Services (8)
WOUND MANAGEMENT TECHNOLOGIES, INC. (7)
Xtant Medical Holdings, Inc. (16)
Zimmer Biomet Holdings (37)
ZimVie Inc. (2)
Zosano Pharma Corp (9)

Recent Contracts

Boston Scientific Corporation 2025 Organic Net Sales Growth Performance Share Program (Boston Scientific, Filed With SEC on November 22, 2024)
Boston Scientific Corporation 2025 Relative Total Shareholder Return Performance Share Program (Boston Scientific, Filed With SEC on November 22, 2024)
Boston Scientific Corporation 2025 Annual Bonus Plan, effective as of January 1, 2025 (Boston Scientific, Filed With SEC on November 22, 2024)
2016 Equity Incentive Plan (EIP) as amended November 7, 2024 (iRhythm Technologies, Inc., Filed With SEC on November 14, 2024)
Second Amendment to the Chromocell Therapeutics Corporation 2023 Equity Incentive Plan (Chromocell Therapeutics Corp, Filed With SEC on November 13, 2024)
CARGO Therapeutics, Inc. Corporate Bonus Plan (CARGO Therapeutics, Inc., Filed With SEC on November 12, 2024)
Form of Restricted Stock Agreement (Employees) under the 2023 Equity Incentive Plan (Electromed, Inc., Filed With SEC on November 12, 2024)
Form of Non-Qualified Stock Option Agreement under the 2023 Equity Incentive Plan (Electromed, Inc., Filed With SEC on November 12, 2024)
Form of Performance Stock Unit Award Agreement (FCF) (adopted fiscal 2025) (Hologic, Filed With SEC on November 8, 2024)
Form of Performance Stock Unit Award Agreement (relative TSR) (adopted fiscal 2025) (Hologic, Filed With SEC on November 8, 2024)
Form of Performance Stock Unit Award Agreement (ROIC) (adopted fiscal 2025) (Hologic, Filed With SEC on November 8, 2024)
Amendment to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (Cytosorbents Corp, Filed With SEC on November 7, 2024)
Eighth Amendment to Lantheus Holdings, Inc. 2015 Equity Incentive Plan (Lantheus Holdings, Inc., Filed With SEC on November 6, 2024)
Form of Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan Restricted Stock Unit Award Agreement (Integra Lifesciences Holdings, Filed With SEC on November 4, 2024)
Form of Stock Option Award Agreement under the SANUWAVE Health, Inc. 2024 Equity Incentive Plan (SANUWAVE Health, Inc., Filed With SEC on October 25, 2024)
Form of Restricted Stock Unit Award Agreement for Non-Employee Directors under the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (Semler Scientific, Inc., Filed With SEC on October 8, 2024)
Form of Restricted Stock Unit Award Agreement for Company Employees and Consultants under the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (Semler Scientific, Inc., Filed With SEC on October 8, 2024)
Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (Semler Scientific, Inc., Filed With SEC on October 8, 2024)
Form of Non-Qualified Stock Option Agreement for Company Employees and Consultants under the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (Semler Scientific, Inc., Filed With SEC on October 8, 2024)
Form of Incentive Stock Option Agreement under the Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (Semler Scientific, Inc., Filed With SEC on October 8, 2024)
Semler Scientific, Inc. 2024 Stock Option and Incentive Plan (Semler Scientific, Inc., Filed With SEC on October 8, 2024)
Aethlon Medical, Inc. 2020 Equity Incentive Plan, as amended to date, Form of Restricted Stock Grant, Form of Option Grant and Agreement (AETHLON MEDICAL INC, Filed With SEC on October 2, 2024)
Form of Extension Letter (Transaction Completion Bonus Award) (Restoration Robotics, Inc., Filed With SEC on September 30, 2024)
Kyverna Therapeutics, Inc. 2024 Inducement Equity Incentive Plan (Kyverna Therapeutics, Inc., Filed With SEC on September 16, 2024)
Description of Fiscal Year 2025 Officer Bonus Plan (Electromed, Inc., Filed With SEC on August 27, 2024)
Senior Executive Incentive Bonus Plan (Bicara Therapeutics Inc., Filed With SEC on August 22, 2024)
Tivic Health System, Inc. Amended and Restated 2021 Equity Incentive Plan, dated August 9, 2024 (Tivic Health Systems, Inc., Filed With SEC on August 13, 2024)
Form of Restricted Stock Award Agreement under the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan (WOUND MANAGEMENT TECHNOLOGIES, INC., Filed With SEC on August 12, 2024)
2021 Equity Incentive Plan, as amended from time to time and Form of Stock Option Agreement, Early Exercise Notice and Restricted Stock Purchase Agreement, and Exercise Notice (Lexeo Therapeutics, Inc., Filed With SEC on August 12, 2024)
Axogen, Inc. Performance-Based Restricted Stock Units Notice Inducement Award Agreement, effective as of August 9, 2024, by and between the Company and Michael Dale (Performance) (AxoGen, Inc., Filed With SEC on August 9, 2024)
Axogen, Inc. Performance-Based Restricted Stock Units Notice Inducement Award Agreement, effective as of August 9, 2024, by and between the Company and Michael Dale (TSR) (AxoGen, Inc., Filed With SEC on August 9, 2024)
SANUWAVE Health, Inc. 2024 Equity Incentive Plan (SANUWAVE Health, Inc., Filed With SEC on August 9, 2024)
Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated effective as of May 29, 2024 (Bausch & Lomb Corp, Filed With SEC on August 1, 2024)
Form of Restricted Stock Unit Agreement for Non-Employee Directors under the 2024 Equity Incentive Plan (CERUS CORP, Filed With SEC on August 1, 2024)
Cerus Corporation 2024 Equity Incentive Plan (CERUS CORP, Filed With SEC on August 1, 2024)
Form of grant notice and terms and conditions for restricted stock units granted in 2024 under the 2011 Long-Term Incentive Plan to non-employee directors (Stryker Corp., Filed With SEC on July 31, 2024)
Amendment to the Cadrenal Therapeutics, Inc. 2022 Successor Equity Incentive Plan (Cadrenal Therapeutics, Inc., Filed With SEC on July 31, 2024)
Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program, as amended and restated (Edwards Lifesciences, Filed With SEC on July 31, 2024)
Amended and Restated Cutera, Inc. 2019 Equity Incentive Plan (Cutera, Inc., Filed With SEC on July 18, 2024)
2024 Stock Incentive Plan (VOLITIONRX LTD, Filed With SEC on July 3, 2024)